Janux (JANX) Rises Almost 50% in a Week on Buyout Rumors

Shares of cancer-biotech Janux Therapeutics, Inc. (JANX) have surged close to 50% in the past week, following a report issued by Bloomberg. The report stated that the company is considering a potential sale after big pharmaceutical companies showed takeover interest.Per the report, JANX is currently evaluating its alternative for the buyout with a financial adviser. Apparently, Janux’s innovative pipeline of cancer candidates is attracting buyout offers from big pharma companies.Shares of Janux have rallied ...